|Other Names||Phosducin-like protein 3, HTPHLP, PhPL3, Viral IAP-associated factor 1, VIAF-1, PDCL3, PhLP2A, VIAF1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13347a was selected from the N-term region of PDCL3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Acts as a chaperone for the angiogenic VEGF receptor KDR/VEGFR2, controlling its abundance and inhibiting its ubiquitination and degradation. Modulates the activation of caspases during apoptosis. Is a substrate for Orgyia pseudotsugata multicapsid polyhedrosis virus (OpMNPV) IAP-mediated ubiquitination.|
|Tissue Location||Expressed in all tissues examined including spleen, thymus, prostate, testis, ovary, small intestine and colon.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene encodes a member of the phosducin-like proteinfamily and is a putative modulator of heterotrimeric G proteins.The protein shares extensive amino acid sequence homology withphosducin. Members of the phosducin-like protein family have beenshown to bind to the beta-gamma subunits of G proteins. [providedby RefSeq].
Stirling, P.C., et al. Mol. Biol. Cell 18(6):2336-2345(2007)Lamesch, P., et al. Genomics 89(3):307-315(2007)Wilkinson, J.C., et al. J. Biol. Chem. 279(49):51091-51099(2004)Lopez, P., et al. J. Biol. Chem. 278(3):1751-1757(2003)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.